Published on GHDx (https://ghdx.healthdata.org)

Pyronaridine-artesunate versus mefloquine plus artesunate for malaria

General Info

Geography 
Burkina Faso (BFA)
Cambodia (KHM)
Côte d'Ivoire (CIV)
India (IND)
United Republic of Tanzania (TZA)
Thailand (THA)
Viet Nam (VNM)
View all
Coverage type 
Country
Time period covered 
January, 2007 - October, 2008
Data type
Scientific literature
Keywords 
Antimalarials, Malaria

Citation

Authors 
Rueangweerayut R, Phyo AP, Uthaisin C, Poravuth Y, Binh TQ, Tinto H, Pénali LK, Valecha N, Tien NT, Abdulla S, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L; Pyronaridine–Artesunate Study Team
Journal 
N Engl J Med
Pages 
1298-309
Publication year 
2012
Suggested citation 
Rueangweerayut R, Phyo AP, Uthaisin C, Poravuth Y, Binh TQ, Tinto H, Pénali LK, Valecha N, Tien NT, Abdulla S, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L; Pyronaridine–Artesunate Study Team. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. N Engl J Med. 2012; 366(14): 1298-309.
Source URL:https://ghdx.healthdata.org/record/pyronaridine-artesunate-versus-mefloquine-plus-artesunate-malaria